酶原激活

  • 网络zymogen activation;activation of zymogen
酶原激活酶原激活
  1. 许多重要的生物过程,如酶原激活、肽激素合成、病毒蛋白加工和受体成熟,均须蛋白质前体加工酶的剪切处理。

    Furin / kexin processing proteases catalyze the proteolysis of large protein precursors involved in many biological processes , such as zymogen activation , peptide hormone synthesis , viral protein processing and receptor maturation , making them potential targets for therapeutic agents .

  2. b.Cu~(2+)作为一种激活剂,直接刺激到原有同工酶的一个酶原,产生酶原激活,使原有同工酶活性增强,故能提高苗木的抗逆性。

    B , Cu2 + , as a activator , directly stimulates one of zymogen of original isoenzyme , produces zymogen activation to enhance original isoenzyme activity , so can raise hardiness of seedlings .

  3. 肿瘤软脑膜-蛛网膜转移时的CSF生长因子和纤维蛋白溶酶原激活剂水平

    CSF levels of growth factors and plasminogen activators in leptomeningeal metastases

  4. 一个组织型纤溶性溶解酶原激活剂(T-pa)非共价类抑制剂的药效模型

    A Feature Based Pharmacophore for Tissue - type Plasminogen Activator non - covalent Inhibitor

  5. 目的溶栓后出血性转化(HemorrhagicTransformation,HT)是重组组织型纤维蛋白溶酶原激活剂(rt-PA)治疗急性缺血性脑卒中的一个重要安全指标。

    Objective Prediction of hemorrhagic transformation ( HT ) in patients treated by intravenous recombinant tissue plasminogen activator ( rt-PA ) is a challenging issue in acute stroke management .

  6. 最近发现SPC促进细胞的移动,诱导成纤维细胞表达与细胞移动有关的血纤维蛋白溶酶原激活剂。

    Recently , a lot of studies have been demonstrated that SPC increased cell migration and induced the expression of plasminogen activator related to cell migration .

  7. 急性脑梗死患者血浆S-100B和尿激酶型纤维溶酶原激活物测定及临床意义

    The Measurement and Clinical Significance of Serm S-100B Protein and Urinary Plasminogen Activator in Patients with Brain Infarction

  8. 结论骨肉瘤中纤维酶原激活系统活性较高,uPA、uPA-R蛋白的高表达反映了肿瘤的恶性生物学行为。

    Conclusions The plasminogen system was more active in osteosarcoma . The high level of uPA and uPA-R oncoproteins reflects the malignancy of the tumors .

  9. 目的观察依那普利对急性心肌梗死(AMI)患者组织型血纤维蛋白溶酶原激活物(tPA)、血纤维蛋白溶酶原激活物抑制物(PAI)及血管紧张素Ⅱ(AⅡ)水平变化。

    Objective To investigate the changes of plasma tissue plasminogen activator ( t PA ), plasminogen activator inhibitor ( PAI ) and angiotensin ⅱ ( A ⅱ) level in patients with acute myocardial infarction ( AMI ) treated by enalapril .

  10. 目的检测急性脑梗死(ACI)患者血浆中S-100B蛋白与尿激酶型纤维溶酶原激活物(uPA)含量变化,探讨其与脑梗死病情严重程度的相关性。

    Objective To measure the content change of S-100B protein and urokinase-type plasminogen activator ( uPA ) in the plasma of patients with cerebral infarction and to study its correlation with neurological deficits and infarct volume .

  11. 阿尔茨海默病大鼠海马N-甲基天冬氨酸受体和丝裂酶原激活蛋白激酶的表达

    Expression of MAPK and NMDAR in the hippocampus of Alzheimer rat

  12. 重组人组织纤维蛋白溶酶原激活剂及突变体的分析

    Analysis of Recombinant Human Tissue Plasminogen Activator and Its Mutants

  13. 鼠肾纤维蛋白溶酶原激活酶的纯化和部分鉴定

    Purification and partial characterization of a tissue plasminogen activator from mouse kidneys

  14. 培养细胞分泌的血纤维蛋白溶酶原激活物的研究

    Studies on plasminogen activators secreted by various cultured cells

  15. 卵巢纤蛋白溶酶原激活因子及其抑制因子的研究

    Studies on ovarian plasminogen activators and their inhibitor

  16. 抗生育药对大鼠培养颗粒细胞纤维蛋白溶酶原激活因子和孕酮分泌的影响

    Effects of Antifertility Compounds on Productions of Plasminogen Activator and Progesterone in Cultured Rat Granulosa Cells

  17. 人正常胚胎和葡萄胎绒毛中纤蛋白溶酶原激活与抑制因子及其尿激酶受体的表达

    Expression of plasminogen activator and plasminogen activator inhibitor in human villi of early pregnancy and hydatidiform mole

  18. 应用一步亲和层析法纯化转基因山羊乳腺定位表达的组织型纤维蛋白溶酶原激活剂

    One step Purification of Tissue type Plasminogen Activator Derived from Expression by Milk Gland of Transgenic Goat Using Affinity Chromatography

  19. 因而,应用不同的酶如尿激酶或组织纤维蛋白溶酶原激活剂来溶解血肿和引流液化的血凝块,成为可供选择的治疗方法。

    Lysis of the hematoma with various enzymes , such as urokinase or tissue plasminogen activator ( TPA ), and drainage of liquefied clot has become an alternative .

  20. 凋亡过程中有Caspase-3酶原蛋白的激活。

    There is the activation of Caspase-3 zymogen protein at the whole process of cells apoptosis .